Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Differential inactivation of caspase-8 in lung cancers.

Shivapurkar N, Toyooka S, Eby MT, Huang CX, Sathyanarayana UG, Cunningham HT, Reddy JL, Brambilla E, Takahashi T, Minna JD, Chaudhary PM, Gazdar AF.

Cancer Biol Ther. 2002 Jan-Feb;1(1):65-9.

PMID:
12170765
2.

Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.

Shivapurkar N, Reddy J, Matta H, Sathyanarayana UG, Huang CX, Toyooka S, Minna JD, Chaudhary PM, Gazdar AF.

Oncogene. 2002 Dec 5;21(55):8510-4.

3.

DNA methylation profiles of lung tumors.

Toyooka S, Toyooka KO, Maruyama R, Virmani AK, Girard L, Miyajima K, Harada K, Ariyoshi Y, Takahashi T, Sugio K, Brambilla E, Gilcrease M, Minna JD, Gazdar AF.

Mol Cancer Ther. 2001 Nov;1(1):61-7.

4.

Epigenetic inactivation of laminin-5-encoding genes in lung cancers.

Sathyanarayana UG, Toyooka S, Padar A, Takahashi T, Brambilla E, Minna JD, Gazdar AF.

Clin Cancer Res. 2003 Jul;9(7):2665-72.

5.

Is caspase-8 a neuroendocrine lung tumor suppressor?

Mazumder S, Almasan A.

Cancer Biol Ther. 2002 Jan-Feb;1(1):70-1. No abstract available.

6.

Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.

Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF.

Clin Cancer Res. 2001 Jul;7(7):1998-2004.

7.

Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.

Harada K, Toyooka S, Shivapurkar N, Maitra A, Reddy JL, Matta H, Miyajima K, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Chaudhary PM, Gazdar AF.

Cancer Res. 2002 Oct 15;62(20):5897-901.

8.

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F.

Oncogene. 2001 Mar 22;20(12):1509-18.

9.

Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.

Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF.

Cancer Res. 2001 Jun 1;61(11):4556-60.

10.
11.

Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype.

Vos MD, Scott FM, Iwai N, Treston AM.

J Cell Biochem Suppl. 1996;24:257-68.

PMID:
8806108
12.

Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.

Virmani AK, Rathi A, Zöchbauer-Müller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.

J Natl Cancer Inst. 2000 Aug 16;92(16):1303-7.

PMID:
10944551
14.

Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.

Wu W, Kemp BL, Proctor ML, Gazdar AF, Minna JD, Hong WK, Mao L.

Cancer Res. 1999 Apr 15;59(8):1846-51.

15.

Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

Kelley MJ, Nakagawa K, Steinberg SM, Mulshine JL, Kamb A, Johnson BE.

J Natl Cancer Inst. 1995 May 17;87(10):756-61.

PMID:
7563154
16.

Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.

Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Williams NN, Kaiser LR, Croce CM.

Cancer Res. 2003 Jun 15;63(12):3352-5.

17.

Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.

Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF.

Int J Cancer. 2003 Aug 20;106(2):198-204.

18.

Molecular genetics of small cell lung carcinoma.

Wistuba II, Gazdar AF, Minna JD.

Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13. Review.

PMID:
11479891
19.

Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.

Hopkins-Donaldson S, Ziegler A, Kurtz S, Bigosch C, Kandioler D, Ludwig C, Zangemeister-Wittke U, Stahel R.

Cell Death Differ. 2003 Mar;10(3):356-64.

20.

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.

Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F.

Oncogene. 2001 Nov 8;20(51):7573-7.

Supplemental Content

Support Center